Avillions Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 179.66%
- Profit Growth -18.59%
- Ebitda 252.06%
- Net Worth 16.34%
- Total Assets 10.64%
About Avillions Laboratories
Avillions Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 July 2019 (Five years and six months 17 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sadhna Kumari and Alok Shankar serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299UR2019PTC010034
-
Company No.
010034
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jul 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Avillions Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadhna Kumari
|
Director | 25-Jul-2019 | Current |
|
Alok Shankar
|
Director | 25-Jul-2019 | Current |
Financial Performance of Avillions Laboratories.
Avillions Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 179.66% increase. The company also saw a substantial fall in profitability, with a 18.59% decrease in profit. The company's net worth Soared by an impressive increase of 16.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avillions Laboratories?
Unlock access to Avillions Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Adeesa Pharchem Private LimitedSadhna Kumari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avillions Laboratories?
Unlock and access historical data on people associated with Avillions Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avillions Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avillions Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.